Follow Us:
Tuesday, May 24, 2022

‘Not shy of bringing other devices under price control’: NPPA

DoP has asked stent makers to submit a weekly report.

Written by Deepak Patel | New Delhi |
February 22, 2017 2:24:35 am
NPPA, DoP, National Pharmaceutical Pricing Authority, DPCO, Department of Pharmaceuticals, business news, medicine news, indian express news NPPA is currently monitoring the prices of devices which have seen sudden hike of more than 10 per cent recently. (Representational image)

The National Pharmaceutical Pricing Authority (NPPA) has clearly stated that if it finds ‘similar exploitative system’ of pricing like what was observed in the stent trade channel, it will not ‘shy away’ from bringing those devices under price control using special powers, which have been provided under section 19 of Drug (Prices Control) Order, 2013, or DPCO, 2013.

Meanwhile, invoking special powers under section 3(1) of DPCO, 2013, the Department of Pharmaceuticals (DoP) on Tuesday asked the stent manufacturing companies to submit a weekly report on stents, which have been produced and distributed till date, and maintain their current supply in the market. The NPPA works under the DoP.

Watch What Else Is making News

“They will also submit a weekly production plan for the next week to NPPA and Drug Controller General of India (DCGI),” said the DOP on Tuesday. Section 3(1) of the DPCO, 2013 states that Centre can “direct formulators to sell the formulations to institutions, hospitals or any agency” with a view to achieve adequate availability “in case of emergency or in circumstances of urgency”. Centre has invoked these powers as it has been receiving reports regarding shortage of stents in hospitals and market.

Best of Express Premium

What makes KuCoin P2P Trading Platform a Good Choice To Buy Crypto?Premium
Airtel Demonstrates Immersive Video Entertainment On 5G; Recreates Kapi...Premium
Is It A Good Idea To Keep One Account For All Your Financial Transactions?Premium
Touching The Sky : SIMS, Pune Alumni On A Path To Make A DifferencePremium

NPPA is currently monitoring the prices of devices which have seen sudden hike of more than 10 per cent recently. “The authority decided to take up on priority, monitoring of prices of devices, (which are not under price control), but reporting more than 10 per cent increase in prices, and to take strict action against erring industries,” said NPPA.

Para 19 of the DPCO, 2013 states that under “extraordinary circumstances”, the NPPA can fix the ceiling price for any drug in public interest.

Latest Comment
View All Comments
Post Comment
Read Comments

For all the latest Business News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard

Featured Stories

Malaika Arora demonstrates three yoga asanas to reduce belly fat; watch
Nikhat Zareen: 'My mother was crying and said no one would marry me. I re...Premium
RRR: SS Rajamouli's epic tests the limits of believability, but nothing i...
Jo Jeeta Wohi Sikander at 30: Akshay Kumar was rejected for this Aamir Kh...Premium
Tea, juices, fruits and one roti: For Sidhu, medical board suggests 7-mea...
Advertisement
Advertisement
Advertisement
X